A BILL 
To require the use of prescription drug monitoring programs. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Prescription Drug 
4
Monitoring Act of 2021’’. 
5
SEC. 2. REQUIRING THE USE OF PRESCRIPTION DRUG 
6
MONITORING PROGRAMS. 
7
(a) DEFINITIONS.—In this section: 
8
(1) 
CONTROLLED
SUBSTANCE.—The 
term 
9
‘‘controlled substance’’ has the meaning given the 
10
term in section 102 of the Controlled Substances 
11
Act (21 U.S.C. 802). 
12
01:49 May 26, 2021
H2344
2 
•HR 2344 IH
(2) COVERED
STATE.—The term ‘‘covered 
1
State’’ means a State that receives funding under 
2
the Harold Rogers Prescription Drug Monitoring 
3
Program established under the Departments of 
4
Commerce, Justice, and State, the Judiciary, and 
5
Related Agencies Appropriations Act, 2002 (Public 
6
Law 107–77; 115 Stat. 748), or under the con-
7
trolled substance monitoring program under section 
8
399O of the Public Health Service Act (42 U.S.C. 
9
280g–3). 
10
(3) DISPENSER.—The term ‘‘dispenser’’— 
11
(A) means a person licensed or otherwise 
12
authorized by a State to deliver a prescription 
13
drug product to a patient or an agent of the pa-
14
tient; and 
15
(B) does not include a person involved in 
16
oversight or payment for prescription drugs. 
17
(4) PDMP.—The term ‘‘PDMP’’ means a pre-
18
scription drug monitoring program. 
19
(5) PRACTITIONER.—The term ‘‘practitioner’’ 
20
means a practitioner registered under section 303(f) 
21
of the Controlled Substances Act (21 U.S.C. 823(f)) 
22
to prescribe, administer, or dispense controlled sub-
23
stances. 
24
01:49 May 26, 2021
H2344
3 
•HR 2344 IH
(6) STATE.—The term ‘‘State’’ means each of 
1
the several States and the District of Columbia. 
2
(b) REQUIREMENTS.—Beginning 1 year after the 
3
date of enactment of this Act, each covered State shall 
4
require— 
5
(1) each prescribing practitioner within the cov-
6
ered State or their designee, who shall be licensed or 
7
registered healthcare professionals or other employ-
8
ees who report directly to the practitioner, to consult 
9
the PDMP of the covered State before initiating 
10
treatment with a prescription for a controlled sub-
11
stance listed in schedule II, III, or IV of section 
12
202(c) of the Controlled Substances Act (21 U.S.C. 
13
812(c)), and every 3 months thereafter as long as 
14
the treatment continues; 
15
(2) the PDMP of the covered State to provide 
16
proactive notification to a practitioner when patterns 
17
indicative of controlled substance misuse, including 
18
opioid misuse, are detected; 
19
(3) each dispenser within the covered State to 
20
report each prescription for a controlled substance 
21
dispensed by the dispenser to the PDMP not later 
22
than 24 hours after the controlled substance is dis-
23
pensed to the patient; 
24
01:49 May 26, 2021
H2344
4 
•HR 2344 IH
(4) that the PDMP make available a quarterly 
1
de-identified data set and an annual report for pub-
2
lic and private use, including use by healthcare pro-
3
viders, health plans and health benefits administra-
4
tors, State agencies, and researchers, which shall, at 
5
a minimum, meet requirements established by the 
6
Attorney General, in coordination with the Secretary 
7
of Health and Human Services; 
8
(5) each State agency that administers the 
9
PDMP to— 
10
(A) proactively analyze data available 
11
through the PDMP; and 
12
(B) provide reports to law enforcement 
13
agencies and prescriber licensing boards de-
14
scribing any prescribing practitioner that re-
15
peatedly fall outside of expected norms or 
16
standard practices for the prescribing practi-
17
tioner’s field; and 
18
(6) that the data contained in the PDMP of the 
19
covered State be made available to other States. 
20
(c) NONCOMPLIANCE.—If a covered State fails to 
21
comply with subsection (a), the Attorney General or the 
22
Secretary of Health and Human Services may withhold 
23
grant funds from being awarded to the covered State 
24
under the Harold Rogers Prescription Drug Monitoring 
25
01:49 May 26, 2021
H2344
5 
•HR 2344 IH
Program established under the Departments of Com-
1
merce, Justice, and State, the Judiciary, and Related 
2
Agencies Appropriations Act, 2002 (Public Law 107–77; 
3
115 Stat. 748), or under the controlled substance moni-
4
toring program under section 399O of the Public Health 
5
Service Act (42 U.S.C. 280g–3). 
6
Æ 
01:49 May 26, 2021
H2344
